A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood
Clinical trial NCT05945888 · COMPLETED
Trial details
- NCT number
- NCT05945888
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-25
- Primary completion
- 2023-11-13
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.